Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality

This secondary analysis of a randomized clinical trial assesses whether screening for prostate-specific antigen reduces prostate cancer mortality at 15-year follow-up.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research